Characterization of virulence factors, antifungal resistance with ERG-11 gene among Candida species isolated from pulmonary samples

Microbial Pathogenesis - Tập 137 - Trang 103750 - 2019
D. Danis Vijay1, S. Jayanthi1, N. Meenakshi2, S.H. Shifa Meharaj1, A. Sujhithra3, J. Perumal1
1Department of Microbiology, Chettinad Hospital and Research Institute (CHRI), Chettinad Academy of Research & Education (CARE), Kelambakkam, 603103, Tamilnadu, India
2Department of Respiratory Medicine, Chettinad Hospital and Research Institute (CHRI), Chettinad Academy of Research & Education (CARE), Kelambakkam, 603103, Tamilnadu, India
3Department of Cardiology, Faculty of Allied Health Sciences (FAHS), Chettinad Hospital and Research Institute (CHRI), Chettinad Academy of Research & Education (CARE), Kelambakkam, 603103, Tamilnadu, India

Tài liệu tham khảo

Yigit, 2011, Investigating biofilm production, coagulase and hemolytic activity in Candida species isolated from denture stomatitis patients, EAJM, 43, 27, 10.5152/eajm.2011.06

Wang, 2015, ERG11 mutations associated with azole resistance in Candida albicans isolates from vulvovaginal candidosis patients, Asian Pac J Trop Biomed, 5, 909, 10.1016/j.apjtb.2015.08.002

Souza et al,"Comparison between four usual methods of identification of Candida species" Rev. Inst. Med. Trop., 57(4):281-287 .doi.org/10.1590/S0036-46652015000400002.

Anuradha, 2018, A multicentre study of antifungal susceptibility patterns among 350 Candida auris isolates (2009–17) in India: role of the ERG11 and FKS1 genes in azole and echinocandin resistance, J. Antimicrob. Chemother., 73, 891, 10.1093/jac/dkx480

N. Yigit et al, "Comparison of the efficacy of different blood medium in determining the hemolytic activity of Candida species", J. Mycol. Med., doi.org/10.1016/j.mycmed.2009.03.005.

Hirota et al, Pathogenic factors in Candida biofilm-related infectious Diseases, J. Appl. Microbiol. 122, 321-330 , doi:10.1111/jam.13330.

Ferreira, 2013, Candida albicans and non-C. Albicans Candida species:comparison of biofilm production and metabolic activity in biofilms, and putative virulence properties of isolates from hospital environments and infections, Mycopathologia, 175, 265, 10.1007/s11046-013-9638-z

CLSI, 2018

H. Wang et al, "In vitro susceptibilities of yeast species to fluconazole and voriconazole as determined by the 2010 national China hospital invasive fungal surveillance net (CHIF-NET) study", J. Clin. Microbiol., doi: 10.1128/JCM.01130-12.

Emilia et al, "Trends in antifungal susceptibility testing using CLSI reference and commercialmethods",Expert Rev. Anti-infect. Ther., doi .org/10.1586/14787210.7.1.107.

Lekshmi et al, Characterization of non albicans candida species and the antifungal susceptibility profile of clinical isolates, Indian J. Microbiol. Res. , DOI: 10.18231/2394-5478.2018.0062.

Guizhen et al, Rapid identification of pathogenic fungi directly from cultures by using multiplex PCR. J. Clin. Microbiol.,DOI: 10.1128/JCM.40.8.2860–2865.2002.

Consuelo et al, Detection and identification of fungal pathogens by PCR and by ITS2 and 5.8S ribosomal DNA typing in ocular infections, J. Clin. Microbiol.,DOI: 10.1128/JCM.39.8.2873–2879.2001.

Josphat, 2017, Antimicrobial susceptibility patterns of bacteria associated with upper respiratory tract infections in kitui, Kenya, Ethiop. Med. J., 55

Omar Sadik et al, Phenotypic and genotypic evaluation of adherence and biofilm development in Candida albicans respiratory tract isolates from hospitalized patients, Rom. J. Lab. Med. Vol. 27, DOI:10.2478/rrlm-2019-0007.

L. Yang et al, Epidemiology, species distribution, antifungal susceptibility, and ERG11 mutations of Candida species isolated from pregnant Chin. Han women,15(2): gmr.15027168, doi.org/10.4238/gmr.15027168.

Dalia, 2016, Species identification and antifungal susceptibility pattern of Candida isolates in cases of vulvovaginal candidiasis, Alexandria J. Med., 52, 269, 10.1016/j.ajme.2015.10.001